ArticleBMC public health2025
Mortality trends in Kazakhstan: insights from a million of deaths from 2014 to 2022.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Population Serum 25-Hydroxyvitamin D Status in Kazakhstan: A Systematic Review and Meta-Analysis.Diagnostics (Basel, Switzerland) · 2026Review
- Epidemiology of Status Epilepticus in Kazakhstan: A 10-Year Population-Based Study.Journal of clinical medicine · 2025Article
- Long-Term Exposure to Ionizing Radiation from the Semipalatinsk Nuclear Test Site and Risk of Cardiovascular Mortality.International journal of environmental research and public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKazakhstan's healthcare system and population health have changed significantly between 2014 and 2022, especially due to the COVID-19 pandemic. This study analyzes mortality trends during this period to better understand the health challenges and regional differences that have emerged, addressing a gap in comprehensive research.
methodsWe analyzed mortality data from Kazakhstan's Unified National Electronic Health System (2014-2022), calculating age-standardized mortality rates and years of life lost. Regional trends were assessed using linear regression.
resultsOverall mortality increased from 550.84 to 678.37 per 100,000 between 2014-2022, with significant regional variations. "Other disorders of the brain" emerged as a leading cause of premature mortality. COVID-19 significantly disrupted mortality patterns in 2020-2021. Mortality rates were consistently higher in males across most age groups, with a sharp increase after age 55, while "other disorders of the brain" emerged as a leading cause of premature mortality.
conclusionsKazakhstan faces evolving mortality challenges, with stark regional disparities and a concerning rise in neurological disorders. These findings underscore the need for targeted public health interventions and improved cause-of-death reporting.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.